Table 3 Electronic medical record variables
Year Prior to Enrollment | Year Post Enrollment | |
|---|---|---|
CPS-C | – | – |
Sickle cell disease | n = 5 | n = 4 |
MCV, M (SD) | 92.74 (15.64) | 96.63 (15.41) |
HbF %, M (SD) | 10.42 (14.62) | 12.93 (14.82) |
Transplant | n = 3 | n = 3 |
MLVI, M (SD) | 1.81 (0.56) | 1.73 (0.80) |
Type 2 diabetes | n = 3 | n = 3 |
HbA1c, M (SD) | 11.77 (2.03) | 12.60 (0.24) |
CPS-T | – | – |
Sickle cell disease | n = 4 | n = 4 |
MCV, M (SD) | 93.44 (3.95) | 96.31 (5.26) |
HbF %, M (SD) | 5.84 (3.85) | 9.02 (6.98) |
Transplant | n = 4 | n = 4 |
MLVI, M (SD) | 2.49 (1.12) | 2.52 (1.85) |
Type 2 diabetes | n = 4 | n = 4 |
HbA1c, M (SD) | 10.91 (2.08) | 12.21 (1.51) |
ATR | – | – |
Sickle cell disease | n = 5 | n = 3 |
MCV, M (SD) | 94.32 (8.21) | 96.64 (9.50) |
HbF %, M (SD) | 18.34 (12.43) | 20.99 (12.75) |
Transplant | n = 3 | n = 3 |
MLVI, M (SD) | 2.07 (1.76) | 1.75 (1.00) |
Type 2 diabetes | n = 3 | n = 3 |
HbA1c, M (SD) | 9.93 (0.98) | 10.22 (1.04) |